Cargando…

Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma

BACKGROUND: Primary pure mucinous adenocarcinoma of the lung (PMA) is a rare subtype. However, correlations between clinicopathological features and genetic phenotypes with survival have not been described comprehensively. METHODS: Pure mucinous adenocarcinoma patient information collected from the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhencong, Li, Ming, Ma, Ke, Shang, Guoguo, Liang, Jiaqi, Yin, Jiacheng, Luo, Jizhuang, Zhan, Cheng, Shi, Yu, Wang, Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970056/
https://www.ncbi.nlm.nih.gov/pubmed/31769218
http://dx.doi.org/10.1002/cam4.2726
_version_ 1783489439980322816
author Chen, Zhencong
Li, Ming
Ma, Ke
Shang, Guoguo
Liang, Jiaqi
Yin, Jiacheng
Luo, Jizhuang
Zhan, Cheng
Shi, Yu
Wang, Qun
author_facet Chen, Zhencong
Li, Ming
Ma, Ke
Shang, Guoguo
Liang, Jiaqi
Yin, Jiacheng
Luo, Jizhuang
Zhan, Cheng
Shi, Yu
Wang, Qun
author_sort Chen, Zhencong
collection PubMed
description BACKGROUND: Primary pure mucinous adenocarcinoma of the lung (PMA) is a rare subtype. However, correlations between clinicopathological features and genetic phenotypes with survival have not been described comprehensively. METHODS: Pure mucinous adenocarcinoma patient information collected from the Surveillance, Epidemiology, and End Results (SEER) database, the Department of Thoracic Surgery, Zhongshan Hospital, Fudan University (FDZSH), and the Cancer Genome Atlas (TCGA) were extracted, evaluated, and compared with other lung adenocarcinomas (LUAD) patient data. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses were performed to explore the functional importance of underlying molecular changes. Overall survival (OS) was evaluated with the Kaplan‐Meier method. Univariate and multivariate analysis through Cox proportional hazard regression identified risk factors that predicted OS, and the results were used to construct a nomogram to predict OS for PMA patients. RESULTS: Overall, 3622 patients, 41 patients, and 15 patients with PMA were identified from the SEER, FDZSH, and TCGA databases, respectively. There were 345 differentially expressed genes, 30 differentially mutated genes and 72 differentially methylated genes were identified between PMA and other LUAD samples. In the SEER database, PMA had a better prognosis compared to other LUAD. Compared with patients with other LUAD, patients with PMA exhibited unique clinicopathological features, including fewer grade III/IV tumors, less pleural invasion, more early‐stage cancer, and more lower lobe carcinomas. Multivariate analyses showed that age, race, T stage, N stage, surgery, and chemotherapy were independent risk factors. The nomogram had a calibration index of 0.724. CONCLUSIONS: Our research identified unique clinicopathological characteristics and genetic phenotypes for PMA and other LUAD. The nomogram accurately predicted OS.
format Online
Article
Text
id pubmed-6970056
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69700562020-01-27 Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma Chen, Zhencong Li, Ming Ma, Ke Shang, Guoguo Liang, Jiaqi Yin, Jiacheng Luo, Jizhuang Zhan, Cheng Shi, Yu Wang, Qun Cancer Med Clinical Cancer Research BACKGROUND: Primary pure mucinous adenocarcinoma of the lung (PMA) is a rare subtype. However, correlations between clinicopathological features and genetic phenotypes with survival have not been described comprehensively. METHODS: Pure mucinous adenocarcinoma patient information collected from the Surveillance, Epidemiology, and End Results (SEER) database, the Department of Thoracic Surgery, Zhongshan Hospital, Fudan University (FDZSH), and the Cancer Genome Atlas (TCGA) were extracted, evaluated, and compared with other lung adenocarcinomas (LUAD) patient data. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses were performed to explore the functional importance of underlying molecular changes. Overall survival (OS) was evaluated with the Kaplan‐Meier method. Univariate and multivariate analysis through Cox proportional hazard regression identified risk factors that predicted OS, and the results were used to construct a nomogram to predict OS for PMA patients. RESULTS: Overall, 3622 patients, 41 patients, and 15 patients with PMA were identified from the SEER, FDZSH, and TCGA databases, respectively. There were 345 differentially expressed genes, 30 differentially mutated genes and 72 differentially methylated genes were identified between PMA and other LUAD samples. In the SEER database, PMA had a better prognosis compared to other LUAD. Compared with patients with other LUAD, patients with PMA exhibited unique clinicopathological features, including fewer grade III/IV tumors, less pleural invasion, more early‐stage cancer, and more lower lobe carcinomas. Multivariate analyses showed that age, race, T stage, N stage, surgery, and chemotherapy were independent risk factors. The nomogram had a calibration index of 0.724. CONCLUSIONS: Our research identified unique clinicopathological characteristics and genetic phenotypes for PMA and other LUAD. The nomogram accurately predicted OS. John Wiley and Sons Inc. 2019-11-25 /pmc/articles/PMC6970056/ /pubmed/31769218 http://dx.doi.org/10.1002/cam4.2726 Text en © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cancer Research
Chen, Zhencong
Li, Ming
Ma, Ke
Shang, Guoguo
Liang, Jiaqi
Yin, Jiacheng
Luo, Jizhuang
Zhan, Cheng
Shi, Yu
Wang, Qun
Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma
title Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma
title_full Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma
title_fullStr Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma
title_full_unstemmed Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma
title_short Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma
title_sort analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma
topic Clinical Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970056/
https://www.ncbi.nlm.nih.gov/pubmed/31769218
http://dx.doi.org/10.1002/cam4.2726
work_keys_str_mv AT chenzhencong analysisoftheclinicopathologicalcharacteristicsgeneticphenotypesandprognosticofpuremucinousadenocarcinoma
AT liming analysisoftheclinicopathologicalcharacteristicsgeneticphenotypesandprognosticofpuremucinousadenocarcinoma
AT make analysisoftheclinicopathologicalcharacteristicsgeneticphenotypesandprognosticofpuremucinousadenocarcinoma
AT shangguoguo analysisoftheclinicopathologicalcharacteristicsgeneticphenotypesandprognosticofpuremucinousadenocarcinoma
AT liangjiaqi analysisoftheclinicopathologicalcharacteristicsgeneticphenotypesandprognosticofpuremucinousadenocarcinoma
AT yinjiacheng analysisoftheclinicopathologicalcharacteristicsgeneticphenotypesandprognosticofpuremucinousadenocarcinoma
AT luojizhuang analysisoftheclinicopathologicalcharacteristicsgeneticphenotypesandprognosticofpuremucinousadenocarcinoma
AT zhancheng analysisoftheclinicopathologicalcharacteristicsgeneticphenotypesandprognosticofpuremucinousadenocarcinoma
AT shiyu analysisoftheclinicopathologicalcharacteristicsgeneticphenotypesandprognosticofpuremucinousadenocarcinoma
AT wangqun analysisoftheclinicopathologicalcharacteristicsgeneticphenotypesandprognosticofpuremucinousadenocarcinoma